# Scott Brun

> Scott Brun is a funding round investor at AbbVie Biotech Ventures backing Medical and Hospital. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [AbbVie Biotech Ventures](https://shizune.co/investors/profile/abbvie-biotech-ventures)
- Location: Chicago, United States
- Total investments: 1
- Last investment: Apr 2017
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/scott-brun-433ba011b/

Scott Brun is a funding round investor at AbbVie Biotech Ventures in Chicago focused on Medical and Hospital. In addition to his role in AbbVie Ventures, Scott is Vice President, Scientific Affairs, and acts as an Abbvie spokesperson on R&D matters to global media, governmental officials, and institutional investors. Prior to this role, Scott led Pharmaceutical Development at AbbVie and was responsible for advancing a broad pipeline across severaltherapeutic areas. In his 20+ year career at Abbott/AbbVie, he held roles of increasing responsibility across the research and development organization.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Hospital | 1 | 100% |
| Health Care | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aquinnah Pharmaceuticals | Aquinnah Pharmaceuticals is focused on an exciting new area of research and development to modulate neurodegenerative stress granules, believed to be important in the pathology of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. | $10M |  | Apr 25, 2017 |  |

1 of 1 investments shown.

## Co-investors
- [Pfizer](https://shizune.co/investors/profile/pfizer) — VC Fund, 1 deal together

## About AbbVie Biotech Ventures

VC Fund · North Chicago, United States

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.

4 contacts available at AbbVie Biotech Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Jay Cui | Manager | https://shizune.co/investors/profile/jay-cui |
| John Gustofson | Managing Director | https://shizune.co/investors/profile/john-gustofson |
| Scott Brun | Head | https://shizune.co/investors/profile/scott-brun |
| Margarita Chavez | Managing Director | https://shizune.co/investors/profile/margarita-chavez |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Scott Brun invest in?

Scott Brun invests primarily in Medical, Hospital and Health Care startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Scott Brun last invest?

The most recent investment recorded for Scott Brun closed in Apr 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co